Logo image of ABT

ABBOTT LABORATORIES (ABT) Stock Price, Quote, News and Overview

NYSE:ABT - New York Stock Exchange, Inc. - US0028241000 - Common Stock - Currency: USD

132.53  -0.29 (-0.22%)

ABT Quote, Performance and Key Statistics

ABBOTT LABORATORIES

NYSE:ABT (5/5/2025, 2:42:02 PM)

132.53

-0.29 (-0.22%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High141.23
52 Week Low99.71
Market Cap229.85B
Shares1.73B
Float1.72B
Yearly Dividend2.21
Dividend Yield1.8%
PE27.73
Fwd PE23.1
Earnings (Next)07-16 2025-07-16/bmo
IPO03-01 1937-03-01


ABT short term performance overview.The bars show the price performance of ABT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

ABT long term performance overview.The bars show the price performance of ABT in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of ABT is 132.53 USD. In the past month the price increased by 0.9%. In the past year, price increased by 25.42%.

ABBOTT LABORATORIES / ABT Daily stock chart

ABT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ISRG INTUITIVE SURGICAL INC 70.13 192.03B
BSX BOSTON SCIENTIFIC CORP 38.78 154.87B
SYK STRYKER CORP 30.58 146.26B
MDT MEDTRONIC PLC 15.67 107.30B
BDX BECTON DICKINSON AND CO 11.91 48.18B
EW EDWARDS LIFESCIENCES CORP 29.02 44.36B
IDXX IDEXX LABORATORIES INC 42.17 38.96B
RMD RESMED INC 26.58 35.39B
GEHC GE HEALTHCARE TECHNOLOGY 15.19 31.98B
DXCM DEXCOM INC 49.13 31.79B
PHG KONINKLIJKE PHILIPS NVR- NY 16.27 24.02B
STE STERIS PLC 24.6 22.19B

About ABT

Company Profile

ABT logo image Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.

Company Info

ABBOTT LABORATORIES

100 Abbott Park Road, Abbot Park

ABBOTT PARK ILLINOIS 60064 US

CEO: Robert B. Ford

Employees: 114000

ABT Company Website

ABT Investor Relations

Phone: 12246676100

ABBOTT LABORATORIES / ABT FAQ

What is the stock price of ABBOTT LABORATORIES today?

The current stock price of ABT is 132.53 USD. The price decreased by -0.22% in the last trading session.


What is the ticker symbol for ABBOTT LABORATORIES stock?

The exchange symbol of ABBOTT LABORATORIES is ABT and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is ABT stock listed?

ABT stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for ABBOTT LABORATORIES stock?

32 analysts have analysed ABT and the average price target is 144.01 USD. This implies a price increase of 8.66% is expected in the next year compared to the current price of 132.53. Check the ABBOTT LABORATORIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ABBOTT LABORATORIES worth?

ABBOTT LABORATORIES (ABT) has a market capitalization of 229.85B USD. This makes ABT a Mega Cap stock.


How many employees does ABBOTT LABORATORIES have?

ABBOTT LABORATORIES (ABT) currently has 114000 employees.


What are the support and resistance levels for ABBOTT LABORATORIES (ABT) stock?

ABBOTT LABORATORIES (ABT) has a support level at 132.65 and a resistance level at 140.23. Check the full technical report for a detailed analysis of ABT support and resistance levels.


Is ABBOTT LABORATORIES (ABT) expected to grow?

The Revenue of ABBOTT LABORATORIES (ABT) is expected to grow by 6.33% in the next year. Check the estimates tab for more information on the ABT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ABBOTT LABORATORIES (ABT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ABBOTT LABORATORIES (ABT) stock pay dividends?

ABBOTT LABORATORIES (ABT) has a dividend yield of 1.8%. The yearly dividend amount is currently 2.21. Check the full fundamental report for a detailed analysis of ABT dividend history, reliability and sustainability.


When does ABBOTT LABORATORIES (ABT) report earnings?

ABBOTT LABORATORIES (ABT) will report earnings on 2025-07-16, before the market open.


What is the Price/Earnings (PE) ratio of ABBOTT LABORATORIES (ABT)?

The PE ratio for ABBOTT LABORATORIES (ABT) is 27.73. This is based on the reported non-GAAP earnings per share of 4.78 and the current share price of 132.53 USD. Check the full fundamental report for a full analysis of the valuation metrics for ABT.


What is the Short Interest ratio of ABBOTT LABORATORIES (ABT) stock?

The outstanding short interest for ABBOTT LABORATORIES (ABT) is 1.26% of its float. Check the ownership tab for more information on the ABT short interest.


ABT Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to ABT. When comparing the yearly performance of all stocks, ABT is one of the better performing stocks in the market, outperforming 87.5% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ABT Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to ABT. Both the health and profitability get an excellent rating, making ABT a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ABT Financial Highlights

Over the last trailing twelve months ABT reported a non-GAAP Earnings per Share(EPS) of 4.78. The EPS increased by 8.88% compared to the year before.


Industry RankSector Rank
PM (TTM) 31.95%
ROA 16.46%
ROE 28.12%
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%11.22%
Sales Q2Q%3.95%
EPS 1Y (TTM)8.88%
Revenue 1Y (TTM)5%

ABT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 79% to ABT. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 11.46% and a revenue growth 6.33% for ABT


Ownership
Inst Owners79.14%
Ins Owners0.45%
Short Float %1.26%
Short Ratio2.96
Analysts
Analysts79.38
Price Target144.01 (8.66%)
EPS Next Y11.46%
Revenue Next Year6.33%